DK0964865T3 - Farmaceutisk virksomme tricycliske aminer - Google Patents

Farmaceutisk virksomme tricycliske aminer

Info

Publication number
DK0964865T3
DK0964865T3 DK97955063T DK97955063T DK0964865T3 DK 0964865 T3 DK0964865 T3 DK 0964865T3 DK 97955063 T DK97955063 T DK 97955063T DK 97955063 T DK97955063 T DK 97955063T DK 0964865 T3 DK0964865 T3 DK 0964865T3
Authority
DK
Denmark
Prior art keywords
pharmaceutically active
tricyclic amines
active tricyclic
amines
pyrimido
Prior art date
Application number
DK97955063T
Other languages
Danish (da)
English (en)
Inventor
Gordon L Bundy
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0964865T3 publication Critical patent/DK0964865T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
DK97955063T 1997-01-08 1997-12-19 Farmaceutisk virksomme tricycliske aminer DK0964865T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3522397P 1997-01-08 1997-01-08
US4374997P 1997-04-09 1997-04-09
PCT/US1997/024300 WO1998042708A2 (en) 1997-01-08 1997-12-19 Pharmaceutically active tricyclic amines

Publications (1)

Publication Number Publication Date
DK0964865T3 true DK0964865T3 (da) 2003-05-05

Family

ID=26711898

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97955063T DK0964865T3 (da) 1997-01-08 1997-12-19 Farmaceutisk virksomme tricycliske aminer

Country Status (23)

Country Link
US (1) US5932728A (de)
EP (1) EP0964865B1 (de)
JP (1) JP2002511061A (de)
KR (1) KR20000069940A (de)
CN (1) CN1128798C (de)
AT (1) ATE233763T1 (de)
AU (1) AU723709B2 (de)
CA (1) CA2275389A1 (de)
CZ (1) CZ288076B6 (de)
DE (1) DE69719563T2 (de)
DK (1) DK0964865T3 (de)
ES (1) ES2193424T3 (de)
FI (1) FI991568A (de)
HK (1) HK1023344A1 (de)
HU (1) HUP0003692A3 (de)
NO (1) NO312463B1 (de)
NZ (1) NZ336659A (de)
PL (1) PL334451A1 (de)
PT (1) PT964865E (de)
RU (1) RU2200737C2 (de)
SI (1) SI0964865T1 (de)
SK (1) SK283378B6 (de)
WO (1) WO1998042708A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282235T3 (es) * 2000-01-31 2007-10-16 Genaera Corporation Inhibidores de la sintesis de la mucina.
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
US7345051B2 (en) 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
MXPA04004019A (es) * 2001-10-31 2004-07-08 Bayer Healthcare Ag Derivados de pirimido?4,5-b?indol.
AU2003300522A1 (en) * 2002-12-27 2004-07-22 Bayer Healthcare Ag 4-phenyl-pyrimido (4,5-b) indole derivatives
JP5838157B2 (ja) * 2009-07-22 2015-12-24 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ Ｈｄａｃ阻害剤およびそれを用いる治療法
AU2012229997B2 (en) 2011-03-15 2016-04-14 Lawrence Livermore National Security, Llc Tricyclic gyrase inhibitors
TR201909582T4 (tr) * 2012-01-27 2019-07-22 Univ Montreal Pirimido[4,5-b]indol türevleri ve hematopoetik kök hücrelerinin ekspresyonunda bunlarin kullanimi.
US10828329B2 (en) 2015-06-05 2020-11-10 Hema-Quebec Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69329574T2 (de) * 1992-04-03 2001-05-31 Upjohn Co Pharmazeutisch wirksame bicyclisch heterocyclische amine
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
NZ304519A (en) * 1995-03-02 2000-01-28 Upjohn Co Pydrimido[4,5-b]indoles

Also Published As

Publication number Publication date
HUP0003692A3 (en) 2002-10-28
NZ336659A (en) 2001-01-26
NO993359D0 (no) 1999-07-07
DE69719563T2 (de) 2003-11-27
CZ238899A3 (cs) 1999-10-13
EP0964865A2 (de) 1999-12-22
KR20000069940A (ko) 2000-11-25
PT964865E (pt) 2003-06-30
HK1023344A1 (en) 2000-09-08
CZ288076B6 (cs) 2001-04-11
JP2002511061A (ja) 2002-04-09
RU2200737C2 (ru) 2003-03-20
NO993359L (no) 1999-09-07
US5932728A (en) 1999-08-03
SK283378B6 (sk) 2003-06-03
ATE233763T1 (de) 2003-03-15
WO1998042708A2 (en) 1998-10-01
PL334451A1 (en) 2000-02-28
CN1239961A (zh) 1999-12-29
ES2193424T3 (es) 2003-11-01
CN1128798C (zh) 2003-11-26
FI991568A (fi) 1999-07-08
DE69719563D1 (de) 2003-04-10
WO1998042708A3 (en) 1998-12-17
AU8655498A (en) 1998-10-20
CA2275389A1 (en) 1998-10-01
SI0964865T1 (en) 2003-08-31
AU723709B2 (en) 2000-09-07
EP0964865B1 (de) 2003-03-05
HUP0003692A2 (hu) 2001-04-28
NO312463B1 (no) 2002-05-13
SK90199A3 (en) 2000-05-16

Similar Documents

Publication Publication Date Title
MX9504332A (es) Derivados de amino(tio)eter y procedimiento para su preparacion.
CA2086434A1 (en) Quinuclidine derivatives
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
MY119181A (en) Aryl pyrimidine derivatives
AU4374396A (en) Imidazo{4,5-c}quinoline amines
HUT74992A (en) Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia
GB9911053D0 (en) 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
BR9906169A (pt) Derivados de pirrolo [1, 2-a] pirazina como ligandos sht 1a
AU1945795A (en) Thieno{ 2,3-b}indoles, their preparation and use
PH31335A (en) Naphthalamides as central nervous system agent.
ATE38227T1 (de) Pharmakologisch aktive derivate von pyrido(1,5)benzodiazepinon.
HUT50767A (en) Process for producing new 1,3,4,5-tetrahydro-benz/c,d/indole derivatives and pharmaceutical compositions comprising such compounds
DK0964865T3 (da) Farmaceutisk virksomme tricycliske aminer
EE9900155A (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetod ja kasutamine raviks
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
YU12397A (en) NOVEL PYRIMIDO [1,2-a] INDOLES
MX9700813A (es) Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
IE840119L (en) Pyrido indoles
CA2303132A1 (en) Intranasal formulations containing scopolamine and method of treating motion sickness
DE60036955D1 (de) HERSTELLUNG VON i3,5,7ö-1H-IMIDAZOi1,5-AöIMIDAZOL-2(3H)-ON-VERBINDUNGEN
IS3938A (is) Aðferð við framleiðslu nýrra pyrimídó [1',6':1,2]pyridó [3,4-b] indól afleiða og lyfjablandna sem innihalda þær
CA2180155A1 (en) Naphthylamides as central nervous system agents